Replicate Bioscience Announces Publication Of First-In-Human Data For Its Optimized Srrna Rabies Vaccine In Nature Communications
Results provide clinical demonstration of best-in-class immunogenicity achieved with an RNA-based platform and good tolerability RBI-4000's ...